Predicting Survival in Patients Receiving Continuous Flow Left Ventricular Assist Devices
Authors:
- Jennifer CowgerJCJennifer Cowger
- Kartik SundareswaranKSKartik Sundareswaran
- Joseph G. RogersJRJoseph G. Rogers
- Soon J. ParkSPSoon J. Park
- Francis D. PaganiFPFrancis D. Pagani
- Geetha BhatGBGeetha Bhat
- Brian JaskiBJBrian Jaski
- David J. FarrarDFDavid J. Farrar
- Mark S. SlaughterMSMark S. Slaughter
Abstract
No abstract availableKeywords
Funding Information
- HeartWare
- Thoratec
- Terumo and HeartWare
- Thoratec
This publication has 21 references indexed in Scilit:
- Risk Assessment for Continuous Flow Left Ventricular Assist Devices: Does the Destination Therapy Risk Score Work?JACC, 2012
- Outcomes in Advanced Heart Failure Patients With Left Ventricular Assist Devices for Destination TherapyCirculation: Heart Failure, 2012
- The Fourth INTERMACS Annual Report: 4,000 implants and countingThe Journal of Heart and Lung Transplantation, 2012
- Results of the Post-U.S. Food and Drug Administration-Approval Study With a Continuous Flow Left Ventricular Assist Device as a Bridge to Heart TransplantationJACC, 2011
- Model for End-Stage Liver Disease Score Predicts Left Ventricular Assist Device Operative Transfusion Requirements, Morbidity, and MortalityCirculation, 2010
- Extended Mechanical Circulatory Support With a Continuous-Flow Rotary Left Ventricular Assist DeviceJACC, 2009
- Use of a Continuous-Flow Device in Patients Awaiting Heart TransplantationNew England Journal of Medicine, 2007
- Outcomes of Left Ventricular Assist Device Implantation as Destination Therapy in the Post-REMATCH EraCirculation, 2007
- Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart FailureNew England Journal of Medicine, 2001
- Screening Scale Predicts Patients Successfully Receiving Long-term Implantable Left Ventricular Assist DevicesCirculation, 1995